Envisagenics

Envisagenics is a company that discovers and develops therapeutic treatments by targeting RNA splicing for oncology and neurodegeneration using its AI platform SpliceCore to power discovery and therapeutic targeting of RNA splicing[1]. The company is headquartered at 30-02 48th Ave, Suites 140 and 150, Long Island City, New York[2].

Something wrong or missing? Send a correction. Fixed within 24 hours.